These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 34486740)

  • 41. Increased postpartum haemorrhage, the possible relation with serotonergic and other psychopharmacological drugs: a matched cohort study.
    Heller HM; Ravelli ACJ; Bruning AHL; de Groot CJM; Scheele F; van Pampus MG; Honig A
    BMC Pregnancy Childbirth; 2017 Jun; 17(1):166. PubMed ID: 28577352
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Safety concerns associated with the use of serotonin reuptake inhibitors and other serotonergic/noradrenergic antidepressants during pregnancy: a review.
    Tuccori M; Testi A; Antonioli L; Fornai M; Montagnani S; Ghisu N; Colucci R; Corona T; Blandizzi C; Del Tacca M
    Clin Ther; 2009 Jun; 31 Pt 1():1426-53. PubMed ID: 19698902
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Low Apgar scores in neonates with prenatal antidepressant exposure.
    Nebhinani N; Soni S
    Br J Psychiatry; 2013 Jun; 202():464. PubMed ID: 23732937
    [No Abstract]   [Full Text] [Related]  

  • 44. Early morbidity and mortality following in utero exposure to selective serotonin reuptake inhibitors: a population-based study in Western Australia.
    Colvin L; Slack-Smith L; Stanley FJ; Bower C
    CNS Drugs; 2012 Jul; 26(7):e1-14. PubMed ID: 22712699
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Neonatal growth outcomes at birth and one month postpartum following in utero exposure to antidepressant medication.
    Lewis AJ; Galbally M; Opie G; Buist A
    Aust N Z J Psychiatry; 2010 May; 44(5):482-7. PubMed ID: 20397792
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Depression in pregnancy: focus on the safety of antidepressant drugs.].
    Vivenzio V; Nardi B; Bellantuono C
    Recenti Prog Med; 2018 Sep; 109(9):432-442. PubMed ID: 30303187
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Neonatal S100B protein levels after prenatal exposure to selective serotonin reuptake inhibitors.
    Pawluski JL; Galea LA; Brain U; Papsdorf M; Oberlander TF
    Pediatrics; 2009 Oct; 124(4):e662-70. PubMed ID: 19786426
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effect of prenatal selective serotonin reuptake inhibitor (SSRI) exposure on birthweight and gestational age: a sibling-controlled cohort study.
    Nezvalová-Henriksen K; Spigset O; Brandlistuen RE; Ystrom E; Koren G; Nordeng H
    Int J Epidemiol; 2016 Dec; 45(6):2018-2029. PubMed ID: 27188860
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Neonatal withdrawal syndrome after in utero exposure to selective serotonin reuptake inhibitors.
    Nordeng H; Lindemann R; Perminov KV; Reikvam A
    Acta Paediatr; 2001 Mar; 90(3):288-91. PubMed ID: 11332169
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Use of antidepressants during pregnancy and neonatal outcomes: An umbrella review of meta-analyses of observational studies.
    Biffi A; Cantarutti A; Rea F; Locatelli A; Zanini R; Corrao G
    J Psychiatr Res; 2020 May; 124():99-108. PubMed ID: 32135392
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The effects of maternal depression and use of antidepressants during pregnancy on risk of a child small for gestational age.
    Jensen HM; Grøn R; Lidegaard O; Pedersen LH; Andersen PK; Kessing LV
    Psychopharmacology (Berl); 2013 Jul; 228(2):199-205. PubMed ID: 23455598
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Neurodevelopment of children following prenatal exposure to venlafaxine, selective serotonin reuptake inhibitors, or untreated maternal depression.
    Nulman I; Koren G; Rovet J; Barrera M; Pulver A; Streiner D; Feldman B
    Am J Psychiatry; 2012 Nov; 169(11):1165-74. PubMed ID: 23128923
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Associations of Maternal Antidepressant Use During the First Trimester of Pregnancy With Preterm Birth, Small for Gestational Age, Autism Spectrum Disorder, and Attention-Deficit/Hyperactivity Disorder in Offspring.
    Sujan AC; Rickert ME; Öberg AS; Quinn PD; Hernández-Díaz S; Almqvist C; Lichtenstein P; Larsson H; D'Onofrio BM
    JAMA; 2017 Apr; 317(15):1553-1562. PubMed ID: 28418479
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effects of in-utero exposure to selective serotonin reuptake inhibitors and venlafaxine on term and preterm infants.
    Hogue AN; Temple-Cooper ME; Lagzdins M; Worley S; Scwersenski J; Floyd R; Saker F
    J Neonatal Perinatal Med; 2017; 10(4):371-380. PubMed ID: 29286926
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pregnancy as a major determinant for discontinuation of antidepressants: an analysis of data from The Health Improvement Network.
    Petersen I; Gilbert RE; Evans SJ; Man SL; Nazareth I
    J Clin Psychiatry; 2011 Jul; 72(7):979-85. PubMed ID: 21457681
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Serotonin reuptake inhibitor-induced perinatal complications.
    Gentile S
    Paediatr Drugs; 2007; 9(2):97-106. PubMed ID: 17407365
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Maternal use of selective serotonin reuptake inhibitors, fetal growth, and risk of adverse birth outcomes.
    El Marroun H; Jaddoe VW; Hudziak JJ; Roza SJ; Steegers EA; Hofman A; Verhulst FC; White TJ; Stricker BH; Tiemeier H
    Arch Gen Psychiatry; 2012 Jul; 69(7):706-14. PubMed ID: 22393202
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Neonatal outcome following pregnancy exposure to antidepressants: a prospective controlled cohort study.
    Maschi S; Clavenna A; Campi R; Schiavetti B; Bernat M; Bonati M
    BJOG; 2008 Jan; 115(2):283-9. PubMed ID: 17903222
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prenatal exposure to antidepressants and persistent pulmonary hypertension of the newborn: systematic review and meta-analysis.
    Grigoriadis S; Vonderporten EH; Mamisashvili L; Tomlinson G; Dennis CL; Koren G; Steiner M; Mousmanis P; Cheung A; Ross LE
    BMJ; 2014 Jan; 348():f6932. PubMed ID: 24429387
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Links between serotonin reuptake inhibition during pregnancy and neurodevelopmental delay/spectrum disorders: A systematic review of epidemiological and physiological evidence.
    Healy D; Le Noury J; Mangin D
    Int J Risk Saf Med; 2016 Sep; 28(3):125-41. PubMed ID: 27662278
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.